Access this stock data via API
Subscribe
Takeda Pharmaceutical Company Limited
0
0
0%

Financials

Income statement

Fundamentals currency is JPY
Fiscal date 2025 2024 2023 2022
Total reported revenue 25.2B 4.3T 4.0T 3.6T
Cost of revenue 8.7B 1.4T 1.2T 1.1T
Gross profit 16.5B 2.8T 2.8T 2.5T
Operating expense
Research & development 4.0B 729.9B 633.3B 526.1B
Selling general and admin 6.1B 1.1T 997.3B 886.4B
Other operating expenses 203.4M 80.3B 55.4B 30.8B
Operating income 2.7B 321.0B 554.9B 546.0B
Non operating interest income
Income 107.8M 11.3B 5.5B 4.6B
Expense 753.8M 119.5B 117.0B 122.4B
Other income expense -929.4M -127.7B -56.4B -120.0B
Pretax income 961.2M 52.8B 375.1B 302.6B
Tax provision 367.5M -91.4B 58.1B 72.4B
Net income 593.7M 144.2B 317.0B 230.2B
Basic EPS 68.4 92.1 204.3 147.1
Diluted EPS 67.2 91.2 201.9 145.9
Basic average shares 8.7M 1.6B 245.1B 246.9B
Diluted average shares 8.7M 1.6B 245.1B 246.9B
EBITDA 6.8B 1.0T 1.2T 1.1T
Net income from continuing op. 593.7M 144.2B 317.0B 230.2B
Minority interests -215M -130M -21M -107M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 4 hours 25 minutes

03:34
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).